Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (1349)
Market Closed
24 Feb, 08:00
HKEX 
3. 20
HKD -0.03
-0.93%
- Market Cap
- P/E Ratio
0.09% Div Yield
868,000 Volume
0 Eps
3.23 HKD
Previous Close Day Range
3.17 3.24
Year Range
2.13 5.29
Want to track 1349 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
1349 earnings report is expected in 35 days (31 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
1349 Earnings Reports FAQ
What is the earnings per share (EPS) for 1349?
The current EPS is 0.
What is the company's earnings growth rate?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-31, based on the 1349's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1349 at this time, as Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
